Thursday, March 23, 2023
Diabetes technology advancements in continuous glucose monitoring (CGM) systems over the last 20+ years have led to integrated CGM (iCGM) devices that allow communication with other technology, including software and continuous subcutaneous insulin-infusion devices (insulin pumps). This expands the ability to prevent hyperglycemia and hypoglycemia beyond an alert -- if clinicians, caregivers, and patients understand the technology. To help clinicians, caregivers, and patients make decisions regarding diabetes technology, this collection page features a series of educational activities that review available iCGM systems, how to use and interpret CGM data from the ambulatory glucose profile (AGP) report, and the role of the entire diabetes healthcare team. In addition, hormone imbalances caused by diabetic ketoacidosis results in production of ketones by the liver, lowering blood pH that can, if left unchecked, cause severe organ damage or death. Thus, in addition to the use of CGM, there could be a benefit to continuously and passively measure the levels of ketones in the blood through continuous ketone monitoring technology.
The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.
The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Medscape Education© Medscape, LLC
Dr Richard Bergenstal speaks to Dr Thomas Martens about the increasing role of CGM and time in range in the management of
people with T2D.
Dr Richard Bergenstal and Dana Gershenoff, RD, discuss how personal and professional CGM can have a positive impact on behavioral
changes.
Richard Bergenstal, MD,interviews Anders Carlson, MD,about how CGM and the time-in-range metric are being used to more effectively
manage T1D
Integrated continuous glucose monitoring (iCGM): A technological revolution for improved diabetes management.
Drs Schatz, Maahs, and Midyet discuss accuracy of and practical tips for using iCGM in pediatric patients with T1D.
Learn why and how time in range helps assess glycemic management in people who have diabetes.
In this roundtable, clinicians who treat people with diabetes discuss the use of the ambulatory glucose profile.
Diana Isaacs, PharmD, and Nick Galloway, RN, discuss the increasing role of CGM in managing diabetes and how to interpret
an AGP report.
In this roundtable, primary care experts in diabetes discuss the role of CGM and the ambulatory glucose profile in identify
hypoglycemia.
New advances in CGM technology and data interpretation have enabled clinicians and patients to better manage diabetes; are
you up to date?
Learn how diabetes educators can help patients with diabetes interpret their glucose reports.
A diabetes nurse and physician assistant review the 9 steps to interpreting data from anambulatoryglucose profile report.
Sue Cornell and Curtis Triplitt discuss the role of pharmacists in increasing understanding of CGM and glucose data using
the AGP.
Review the role of CGM in managing diabetes and how to interpret glucose data using the ambulatory glucose profile.
Learn how CGM data combined with the ambulatory glucose profile can help better inform treatment decisions in regards to diabetes
management.
In this series of interviews, experts in diabetes discuss advances in CGM and the use of this technology in different patient
populations.
Glucose monitoring has evolved; are you up to date on the latest advances and developments?
Irl B. Hirsh, MD, and Davida F. Kruger, MSN, use patient case studies to discuss the value of the ambulatory glucose report
in treating diabetes.
Richard Bergenstal, MD, gives an overview of the newest methods for collecting and interpreting glucose data for patients
with diabetes.
Learn about new advances in glucose data collection and interpretation with leading experts Roger Mazze and Margaret Powers.
In this roundtable, diabetes experts discuss the clinical application of new advances in glucose data collection and interpretation.
Drs Hirsch and Bailey discuss advances in glucose data collection and how the AGP can aid decision making in patients who
have diabetes.